Ghent University Academic Bibliography

Journal Article
A1
open access

The super enhancer-driven long noncoding RNA PRKCQ-AS1 promotes neuroblastoma tumorigenesis by interacting with MSI2 protein and is targetable by small molecule compounds

Sujanna Mondal, Pei Y. Liu, Janith Seneviratne, Antoine De Weck, Pooja Venkat, Chelsea Mayoh, Jing Wu, Jesper Maag, Jingwei Chen, Matthew Wong, et al.

(2025) ADVANCED SCIENCE. 12(18).

Add to list

Journal Article
A1
open access

Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma

Elien Hilgert (UGent) , Christophe Van Neste (UGent) , Sarah-Lee Bekaert (UGent) , Fien Martens (UGent) , Suzanne Vanhauwaert (UGent) , Ellen Sanders (UGent) , Peter Verstraelen, Martijn Risseeuw (UGent) , Ellen M. Westerhout, Mark A. Grannetia, et al.

(2025) SCIENTIFIC REPORTS. 15(1).

Add to list

A phase 1 dose‐escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma

Steven G. DuBois, Chitose Ogawa, Lucas Moreno, Yaël P. Mossé, Matthias Fischer, Anne L. Ryan, Kieuhoa T. Vo, Bram De Wilde (UGent) , Alba Rubio‐San‐Simon, Margaret E. Macy, et al.

(2025) CANCER. 131(4).

Add to list

PhD Thesis

Human pluripotent stem cell modeling, from normal development to neuroblastoma

Stéphane Van Haver

(2024)

Add to list

Journal Article
A2
open access

DNA repair and replicative stress addiction in neuroblastoma

Kaat Durinck (UGent) and Meredith S. Irwin

(2024) EJC PAEDIATRIC ONCOLOGY. 4.

Add to list

Journal Article
A1
open access

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

Marcus Borenäs, Ganesh Umapathy, Dan E. Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan Linus Gabre (UGent) , et al.

(2024) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 121(1).

Add to list

Journal Article
A1
open access

Long non-coding RNAs in neuroblastoma : pathogenesis, biomarkers and therapeutic targets

Niels Vercouillie, Zhiyao Ren (UGent) , Eva Terras (UGent) and Tim Lammens (UGent)

(2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(11).

Add to list

Journal Article
A1
open access

Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells

Roberto Fernández-Acosta, Behrouz Hassannia (UGent) , Jurgen Caroen (UGent) , Bartosz Wiernicki, Daniel Alvarez-Alminaque, Bruno Verstraeten (UGent) , Johan Van der Eycken (UGent) , Peter Vandenabeele (UGent) , Tom Vanden Berghe (UGent) and Gilberto L. Pardo-Andreu

(2023) CELLS. 12(5).

Add to list

Journal Article
A1
open access

Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma

Muhammad Rishfi (UGent) , Simon Krols (UGent) , Fien Martens (UGent) , Sarah-Lee Bekaert (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , Fanny De Vloed (UGent) , Joshua Robert Goulding (UGent) , Martijn Risseeuw (UGent) , Jan Molenaar, et al.

(2023) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 247.

Add to list

Journal Article
A1
open access

Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma

Lei Zhai, Anushree Balachandran, Rebecca Larkin, Janith A. Seneviratne, Sylvia A. Chung, Amit Lalwani, Shoma Tsubota, Dominik Beck, Kenji Kadomatsu, Anneleen Beckers (UGent) , et al.

(2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(21).

Academic Bibliography

The super enhancer-driven long noncoding RNA PRKCQ-AS1 promotes neuroblastoma tumorigenesis by interacting with MSI2 protein and is targetable by small molecule compounds

Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma

A phase 1 dose‐escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma

Human pluripotent stem cell modeling, from normal development to neuroblastoma

DNA repair and replicative stress addiction in neuroblastoma

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

Long non-coding RNAs in neuroblastoma : pathogenesis, biomarkers and therapeutic targets

Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells

Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma

Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma

Contents

Support

Contact